Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline eyes rare disease to widen its respiratory lead
GlaxoSmithKline eyes rare disease to widen its respiratory lead
GlaxoSmithKline eyes rare disease to widen its respiratory lead
Submitted by
admin
on February 14, 2014 - 1:07pm
Source:
Fierce Biotech
News Tags:
GSK
mepolizumab
EGPA
Headline:
GlaxoSmithKline eyes rare disease to widen its respiratory lead
Do Not Allow Advertisers to Use My Personal information
